Dr Reddy’s launches generic dementia drug in US

23 Sep 2011 Evaluate

Dr Reddy’s Laboratories Ltd has launched Rivastigmine Tartrate capsules in the US market. The capsules are a bioequivalent generic version of Exelon capsules (of Novartis Pharmaceuticals Corporation) in the US market. They are indicated for the treatment of mild to moderate dementia of the Alzheimer’s type. The Exelon brand and generic rivastigmine tartrate had U.S. sales of approximately $92.6 million for the most recent twelve months ending June 2011.

Dr. Reddys Lab Share Price

5784.50 -92.20 (-1.57%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.